InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences combines AI/ML, glycoproteomics & LCMS for biomarker and target discovery.
Type
B2c
Founded
2017
Raised
$34M
Follow us
Alexa global traffic share
19 Nov 2020
$34,000,000
Venture capital (Series B)

Malaysian VC Xeraya Capital joins US biotech firm InterVenn's US$34M round | e27

e27: Asia tech news
+1